- Report
- May 2025
- 150 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 181 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 199 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 354 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- June 2025
- 185 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- June 2025
- 81 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- April 2023
- 110 Pages
Global
From €4148EUR$4,750USD£3,604GBP
Iron Dextran is a hematological drug used to treat iron deficiency anemia. It is a complex of iron and dextran, a polysaccharide, and is administered intravenously. Iron Dextran is used to replenish iron stores in the body, which are necessary for the production of hemoglobin, the oxygen-carrying component of red blood cells. Iron Dextran is also used to treat anemia caused by chronic kidney disease, chemotherapy, and other conditions.
Iron Dextran is available in both generic and branded forms. Common brand names include Dexferrum, INFeD, and Imferon. These products are manufactured by a variety of companies, including American Regent, Baxter, and Hospira. Show Less Read more
